NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML

Int J Mol Sci. 2021 Oct 22;22(21):11434. doi: 10.3390/ijms222111434.

Abstract

NKL homeobox genes encode transcription factors that impact normal development and hematopoietic malignancies if deregulated. Recently, we established an NKL-code that describes the physiological expression pattern of eleven NKL homeobox genes in the course of hematopoiesis, allowing evaluation of aberrantly activated NKL genes in leukemia/lymphoma. Here, we identify ectopic expression of NKL homeobox gene NKX2-4 in an erythroblastic acute myeloid leukemia (AML) cell line OCI-M2 and describe investigation of its activating factors and target genes. Comparative expression profiling data of AML cell lines revealed in OCI-M2 an aberrantly activated program for endothelial development including master factor ETV2 and the additional endothelial signature genes HEY1, IRF6, and SOX7. Corresponding siRNA-mediated knockdown experiments showed their role in activating NKX2-4 expression. Furthermore, the ETV2 locus at 19p13 was genomically amplified, possibly underlying its aberrant expression. Target gene analyses of NKX2-4 revealed activated ETV2, HEY1, and SIX5 and suppressed FLI1. Comparative expression profiling analysis of public datasets for AML patients and primary megakaryocyte-erythroid progenitor cells showed conspicuous similarities to NKX2-4 activating factors and the target genes we identified, supporting the clinical relevance of our findings and developmental disturbance by NKX2-4. Finally, identification and target gene analysis of aberrantly expressed NKX2-3 in AML patients and a megakaryoblastic AML cell line ELF-153 showed activation of FLI1, contrasting with OCI-M2. FLI1 encodes a master factor for myelopoiesis, driving megakaryocytic differentiation and suppressing erythroid differentiation, thus representing a basic developmental target of these homeo-oncogenes. Taken together, we have identified aberrantly activated NKL homeobox genes NKX2-3 and NKX2-4 in AML, deregulating genes involved in megakaryocytic and erythroid differentiation processes, and thereby contributing to the formation of specific AML subtypes.

Keywords: HOX-code; NKL-code; TALE-code; TBX-code.

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Cell Cycle Proteins / genetics
  • Cell Differentiation / genetics
  • Cell Line, Tumor
  • Endothelium / cytology
  • Erythroid Cells / cytology*
  • Gene Expression Profiling
  • Gene Expression Regulation / genetics
  • Homeodomain Proteins / genetics*
  • Humans
  • Interferon Regulatory Factors / genetics
  • Leukemia, Erythroblastic, Acute / genetics*
  • Leukemia, Erythroblastic, Acute / pathology
  • Megakaryocytes / cytology*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • SOXF Transcription Factors / genetics
  • Transcription Factors / genetics*
  • Vascular Endothelial Growth Factor Receptor-1 / genetics

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Cell Cycle Proteins
  • ETV2 protein, human
  • HEY1 protein, human
  • Homeodomain Proteins
  • IRF6 protein, human
  • Interferon Regulatory Factors
  • NKX2-3 protein, human
  • NKX2-4 protein, human
  • RNA, Small Interfering
  • SOX7 protein, human
  • SOXF Transcription Factors
  • Transcription Factors
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1